Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Academic Licensing Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: PRS008
MIFTS: 26

Prostate Small Cell Carcinoma

Categories: Cancer diseases, Reproductive diseases, Respiratory diseases
Genes Variations Tissues Related diseases Publications Drugs
Sources

Aliases & Classifications for Prostate Small Cell Carcinoma

About this section

MalaCards integrated aliases for Prostate Small Cell Carcinoma:

Name: Prostate Small Cell Carcinoma 12 15
Small Cell Carcinoma of Prostate 12 73
Prostate Oat Cell Carcinoma 12

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Reproductive diseases Respiratory diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:7141
NCIt 50 C6766
SNOMED-CT 68 396198006
UMLS 73 C1300585
Sources

Summaries for Prostate Small Cell Carcinoma

About this section
MalaCards based summary : Prostate Small Cell Carcinoma, also known as small cell carcinoma of prostate, is related to small cell carcinoma and prostatitis. An important gene associated with Prostate Small Cell Carcinoma is SV2B (Synaptic Vesicle Glycoprotein 2B). The drugs Olaparib and Cediranib have been mentioned in the context of this disorder. Affiliated tissues include prostate, skin and brain, and related phenotypes are Decreased viability in esophageal squamous lineage and Increased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor)

Sources

Related Diseases for Prostate Small Cell Carcinoma

About this section

Diseases related to Prostate Small Cell Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 14)
# Related Disease Score Top Affiliating Genes
1 small cell carcinoma 29.1 ASCL1 ENO2 KLK3
2 prostatitis 10.4
3 adenocarcinoma 10.0
4 suppression of tumorigenicity 12 9.9
5 small cell carcinoma of the bladder 9.7
6 nodular prostate 9.6 ENO2 KLK3
7 rete testis adenocarcinoma 9.6 ENO2 KLK3
8 rete testis neoplasm 9.6 ENO2 KLK3
9 large cell neuroendocrine carcinoma 9.5 ASCL1 ENO2
10 cell type cancer 9.4 ENO2 KLK3
11 neuroendocrine tumor 9.3 ASCL1 ENO2
12 small cell cancer of the lung 9.2 ASCL1 ENO2
13 pheochromocytoma 9.0 ASCL1 ENO2
14 neuroblastoma 8.7 ASCL1 AURKA ENO2

Graphical network of the top 20 diseases related to Prostate Small Cell Carcinoma:



Diseases related to Prostate Small Cell Carcinoma
Sources

Symptoms & Phenotypes for Prostate Small Cell Carcinoma

About this section

GenomeRNAi Phenotypes related to Prostate Small Cell Carcinoma according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability in esophageal squamous lineage GR00235-A 9.26 ASCL1 AURKA KLK3 SV2B
2 Increased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor) GR00198-A-1 8.62 ASCL1 AURKA

MGI Mouse Phenotypes related to Prostate Small Cell Carcinoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 taste/olfaction MP:0005394 8.62 ASCL1 ENO2
Sources

Drugs & Therapeutics for Prostate Small Cell Carcinoma

About this section

Drugs for Prostate Small Cell Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):


# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Olaparib Approved Phase 2 763113-22-0 23725625
2
Cediranib Investigational Phase 2 288383-20-0 9933475
3 Poly(ADP-ribose) Polymerase Inhibitors Phase 2
4 Protein Kinase Inhibitors Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Olaparib With or Without Cediranib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Recruiting NCT02893917 Phase 2 Cediranib;Olaparib
2 Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate Not yet recruiting NCT03582475 Phase 1 Carboplatin;Cisplatin;Docetaxel;Etoposide

Search NIH Clinical Center for Prostate Small Cell Carcinoma

Sources

Genetic Tests for Prostate Small Cell Carcinoma

About this section
Sources

Anatomical Context for Prostate Small Cell Carcinoma

About this section

MalaCards organs/tissues related to Prostate Small Cell Carcinoma:

41
Prostate, Skin, Brain
Sources

Publications for Prostate Small Cell Carcinoma

About this section

Articles related to Prostate Small Cell Carcinoma:

(show all 22)
# Title Authors Year
1
Solitary Spinal Epidural Metastasis from Prostatic Small Cell Carcinoma. ( 27413569 )
2016
2
Overlap of CD44 expression between prostatic small cell carcinoma and acinar adenocarcinoma. ( 25656929 )
2015
3
Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma. ( 24777847 )
2015
4
Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas. ( 26246306 )
2015
5
Primary small cell carcinoma of prostate without immunoreactive neuroendocrine proteins but with expressions of KIT and platelet-derived growth factor-I+ ( 25195713 )
2014
6
Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistry. ( 23850495 )
2013
7
Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway. ( 22389383 )
2012
8
Re: PC3 is a cell line characteristic of prostatic small cell carcinoma. ( 22682868 )
2012
9
PC3 is a cell line characteristic of prostatic small cell carcinoma. ( 21432867 )
2011
10
ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. ( 21499238 )
2011
11
ERG gene rearrangements are common in prostatic small cell carcinomas. ( 21336263 )
2011
12
CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers. ( 18835619 )
2009
13
[Clinicopathological characterization of prostatic small cell carcinoma: a case report and review of the literature]. ( 19947569 )
2009
14
Prostate small cell carcinoma and skin metastases: a rare entity. ( 18408396 )
2008
15
Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts. ( 18247403 )
2008
16
Submandibular area metastasis from prostate small cell carcinoma with neuroendocrine differentiation. ( 17912103 )
2007
17
Establishment of a prostatic small-cell carcinoma cell line (SO-MI). ( 12772193 )
2003
18
Brain metastasis from prostate small cell carcinoma: not to be neglected. ( 12463494 )
2002
19
Diagnosing and treating small-cell carcinomas of prostatic origin. ( 11805477 )
2002
20
[A case of prostatic small cell carcinoma]. ( 10934615 )
2000
21
WISH-PC2: a unique xenograft model of human prostatic small cell carcinoma. ( 11118033 )
2000
22
Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndrome. ( 2536972 )
1989
Sources

Variations for Prostate Small Cell Carcinoma

About this section

Cosmic variations for Prostate Small Cell Carcinoma:

9
(show top 50) (show all 122)
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)		 Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM4062730 ZFHX3 prostate,NS,carcinoma,small cell carcinoma c.709C>T p.R237* 16:72959437-72959437 11
2 COSM6921648 YAP1 prostate,NS,carcinoma,small cell carcinoma c.952C>T p.Q318* 11:102223703-102223703 11
3 COSM6921999 WT1 prostate,NS,carcinoma,small cell carcinoma c.322C>G p.R108G 11:32434820-32434820 11
4 COSM6921997 WT1 prostate,NS,carcinoma,small cell carcinoma c.340C>T p.P114S 11:32434802-32434802 11
5 COSM10662 TP53 prostate,NS,carcinoma,small cell carcinoma c.743G>A p.R248Q 17:7674220-7674220 11
6 COSM44510 TP53 prostate,NS,carcinoma,small cell carcinoma c.717C>G p.N239K 17:7674246-7674246 11
7 COSM10889 TP53 prostate,NS,carcinoma,small cell carcinoma c.536A>G p.H179R 17:7675076-7675076 11
8 COSM29760 TP53 prostate,NS,carcinoma,small cell carcinoma c.673-2A>C p.? 17:7674292-7674292 11
9 COSM10648 TP53 prostate,NS,carcinoma,small cell carcinoma c.524G>A p.R175H 17:7675088-7675088 11
10 COSM10704 TP53 prostate,NS,carcinoma,small cell carcinoma c.844C>T p.R282W 17:7673776-7673776 11
11 COSM44682 TP53 prostate,NS,carcinoma,small cell carcinoma c.568C>T p.P190S 17:7674963-7674963 11
12 COSM6916401 SUFU prostate,NS,carcinoma,small cell carcinoma c.196G>T p.D66Y 10:102509182-102509182 11
13 COSM6929784 STAT5B prostate,NS,carcinoma,small cell carcinoma c.319C>T p.R107C 17:42224835-42224835 11
14 COSM219965 SPOP prostate,NS,carcinoma,small cell carcinoma c.397T>G p.F133V 17:49619064-49619064 11
15 COSM6921641 SMO prostate,NS,carcinoma,small cell carcinoma c.1754A>C p.Q585P 7:129211066-129211066 11
16 COSM5621806 SETD2 prostate,NS,carcinoma,small cell carcinoma c.4039C>T p.R1347C 3:47084232-47084232 11
17 COSM899738 SDHB prostate,NS,carcinoma,small cell carcinoma c.688C>T p.R230C 1:17022685-17022685 11
18 COSM6916403 RPS6KA4 prostate,NS,carcinoma,small cell carcinoma c.860C>T p.A287V 11:64361956-64361956 11
19 COSM6913288 RB1 prostate,NS,carcinoma,small cell carcinoma c.1814+1G>T p.? 13:48453112-48453112 11
20 COSM938 RB1 prostate,NS,carcinoma,small cell carcinoma c.967G>T p.E323* 13:48367521-48367521 11
21 COSM6929781 POLE prostate,NS,carcinoma,small cell carcinoma c.2264T>C p.V755A 12:132667558-132667558 11
22 COSM5760562 PIK3R1 prostate,NS,carcinoma,small cell carcinoma c.1746-1G>A p.? 5:68295419-68295419 11
23 COSM6921639 PIK3R1 prostate,NS,carcinoma,small cell carcinoma c.469A>C p.N157H 5:68273980-68273980 11
24 COSM6926748 PIK3CD prostate,NS,carcinoma,small cell carcinoma c.2608C>T p.R870* 1:9723982-9723982 11
25 COSM1220603 PIK3CD prostate,NS,carcinoma,small cell carcinoma c.113G>A p.R38H 1:9710568-9710568 11
26 COSM6916392 PIK3CD prostate,NS,carcinoma,small cell carcinoma c.2681G>A p.R894Q 1:9724055-9724055 11
27 COSM86046 PIK3CA prostate,NS,carcinoma,small cell carcinoma c.316G>C p.G106R 3:179199141-179199141 11
28 COSM6947213 PARP1 prostate,NS,carcinoma,small cell carcinoma c.770C>G p.S257* 1:226386390-226386390 11
29 COSM6929778 NSD1 prostate,NS,carcinoma,small cell carcinoma c.5816G>A p.R1939H 5:177280758-177280758 11
30 COSM6947255 NOTCH2 prostate,NS,carcinoma,small cell carcinoma c.3779G>A p.R1260H 1:119929089-119929089 11
31 COSM6918331 NOTCH1 prostate,NS,carcinoma,small cell carcinoma c.4659G>C p.E1553D 9:136505032-136505032 11
32 COSM3961569 NFE2L2 prostate,NS,carcinoma,small cell carcinoma c.1390C>G p.L464V 2:177231213-177231213 11
33 COSM6918329 MSH2 prostate,NS,carcinoma,small cell carcinoma c.907G>C p.D303H 2:47414383-47414383 11
34 COSM6916405 KMT2A prostate,NS,carcinoma,small cell carcinoma c.11357G>A p.R3786H 11:118520001-118520001 11
35 COSM6922000 IRS2 prostate,NS,carcinoma,small cell carcinoma c.3366G>C p.Q1122H 13:109782688-109782688 11
36 COSM6960356 IRS2 prostate,NS,carcinoma,small cell carcinoma c.553G>T p.G185W 13:109785501-109785501 11
37 COSM496 HRAS prostate,NS,carcinoma,small cell carcinoma c.181C>A p.Q61K 11:533875-533875 11
38 COSM227099 H3F3C prostate,NS,carcinoma,small cell carcinoma c.289G>A p.E97K 12:31791878-31791878 11
39 COSM6918334 GRIN2A prostate,NS,carcinoma,small cell carcinoma c.3662T>C p.M1221T 16:9763882-9763882 11
40 COSM332280 GRIN2A prostate,NS,carcinoma,small cell carcinoma c.3506G>A p.R1169Q 16:9764038-9764038 11
41 COSM6940832 FOXP1 prostate,NS,carcinoma,small cell carcinoma c.1708A>T p.N570Y 3:70970750-70970750 11
42 COSM6947218 FOXA1 prostate,NS,carcinoma,small cell carcinoma c.511C>T p.P171S 14:37592273-37592273 11
43 COSM3738526 FOXA1 prostate,NS,carcinoma,small cell carcinoma c.655C>A p.R219S 14:37592129-37592129 11
44 COSM6908932 FLT4 prostate,NS,carcinoma,small cell carcinoma c.81G>T p.M27I 5:180631756-180631756 11
45 COSM6916397 FGFR4 prostate,NS,carcinoma,small cell carcinoma c.310C>T p.R104* 5:177090608-177090608 11
46 COSM6916407 ERBB2 prostate,NS,carcinoma,small cell carcinoma c.1318G>A p.A440T 17:39715744-39715744 11
47 COSM6921995 EPHB1 prostate,NS,carcinoma,small cell carcinoma c.758G>T p.C253F 3:134952005-134952005 11
48 COSM6947215 EPHB1 prostate,NS,carcinoma,small cell carcinoma c.1601A>C p.E534A 3:135165983-135165983 11
49 COSM6930618 EPHA5 prostate,NS,carcinoma,small cell carcinoma c.2726A>T p.Q909L 4:65336058-65336058 11
50 COSM6921640 EGFR prostate,NS,carcinoma,small cell carcinoma c.2279T>C p.L760P 7:55174816-55174816 11
Sources

Expression for Prostate Small Cell Carcinoma

About this section
Search GEO for disease gene expression data for Prostate Small Cell Carcinoma.
Sources

Pathways for Prostate Small Cell Carcinoma

About this section
Sources

GO Terms for Prostate Small Cell Carcinoma

About this section
Sources

Sources for Prostate Small Cell Carcinoma

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....